Cauwenberge 1978.
Study characteristics | ||
Methods | Study design: randomised, double‐blind, placebo‐controlled Method of randomisation: not stated Exclusions post randomisation: not stated Losses to follow‐up: 51/120 (42.5%) |
|
Participants | Country: Belgium Setting: Liège Number: 120 patients Age: 'adults' Gender: not stated Inclusion criteria: varicose veins, postphlebitic syndrome Exclusion criteria: symptoms not attributed to CVI |
|
Interventions | Treatment: O‐(beta‐hydroxyethyl)‐rutoside 1200 mg per day Control: placebo Duration: 90 days Follow‐up: 90 days |
|
Outcomes | Primary
Secondary
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "The patients are divided into two series according to the degree of symptoms. Within these two series, patients were distributed randomly into two groups, receiving respectively the active ingredient or placebo" Comment: no method of randomisation stated |
Allocation concealment (selection bias) | Unclear risk | Comment: no method of allocation concealment stated |
Blinding (patients) | Low risk | Quote: "We also used a placebo of identical presentation" Comment: Identical placebo ensure double‐blinding |
Blinding (study researchers) | Low risk | Quote: "We also used a placebo of identical presentation" Comment: Identical placebo ensure double‐blinding |
Blinding (outcome assessment) | Low risk | Quote: "We also used a placebo of identical presentation" Comment: Identical placebo ensure double‐blinding |
Incomplete outcome data | High risk | Comment: number of participants in each group described, but no information given on important characteristics of participants. Number of persons excluded after randomisation was important (51/120; 42.5%). Reasons for exclusion were given |
Selective reporting | Low risk | Comment: no published protocol identified, and no differences between outcomes reported in the methods section and those reported in the results section |
Other bias | Low risk | Comment: none detected |